Cargando…
A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems
A fluidized bed bioreactor containing encapsulated hepatocytes may be a valuable alternative to a hollow fiber bioreactor for achieving the improved mass transfer and scale-up potential necessary for clinical use. However, a conventional fluidized bed bioreactor (FBB) operating under high perfusion...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739599/ https://www.ncbi.nlm.nih.gov/pubmed/26840840 http://dx.doi.org/10.1371/journal.pone.0147376 |
_version_ | 1782413776855760896 |
---|---|
author | Lu, Juan Zhang, Xiaoqian Li, Jianzhou Yu, Liang Chen, Ermei Zhu, Danhua Zhang, Yimin Li, LanJuan |
author_facet | Lu, Juan Zhang, Xiaoqian Li, Jianzhou Yu, Liang Chen, Ermei Zhu, Danhua Zhang, Yimin Li, LanJuan |
author_sort | Lu, Juan |
collection | PubMed |
description | A fluidized bed bioreactor containing encapsulated hepatocytes may be a valuable alternative to a hollow fiber bioreactor for achieving the improved mass transfer and scale-up potential necessary for clinical use. However, a conventional fluidized bed bioreactor (FBB) operating under high perfusion velocity is incapable of providing the desired performance due to the resulting damage to cell-containing microcapsules and large void volume. In this study, we developed a novel diversion-type microcapsule-suspension fluidized bed bioreactor (DMFBB). The void volume in the bioreactor and stability of alginate/chitosan microcapsules were investigated under different flow rates. Cell viability, synthesis and metabolism functions, and expression of metabolizing enzymes at transcriptional levels in an encapsulated hepatocyte line (C3A cells) were determined. The void volume was significantly less in the novel bioreactor than in the conventional FBB. In addition, the microcapsules were less damaged in the DMFBB during the fluidization process as reflected by the results for microcapsule retention rates, swelling, and breakage. Encapsulated C3A cells exhibited greater viability and CYP1A2 and CYP3A4 activity in the DMFBB than in the FBB, although the increases in albumin and urea synthesis were less prominent. The transcription levels of several CYP450-related genes and an albumin-related gene were dramatically greater in cells in the DMFBB than in those in the FBB. Taken together, our results suggest that the DMFBB is a promising alternative for the design of a bioartificial liver system based on a fluidized bed bioreactor with encapsulated hepatocytes for treating patients with acute hepatic failure or other severe liver diseases. |
format | Online Article Text |
id | pubmed-4739599 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47395992016-02-11 A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems Lu, Juan Zhang, Xiaoqian Li, Jianzhou Yu, Liang Chen, Ermei Zhu, Danhua Zhang, Yimin Li, LanJuan PLoS One Research Article A fluidized bed bioreactor containing encapsulated hepatocytes may be a valuable alternative to a hollow fiber bioreactor for achieving the improved mass transfer and scale-up potential necessary for clinical use. However, a conventional fluidized bed bioreactor (FBB) operating under high perfusion velocity is incapable of providing the desired performance due to the resulting damage to cell-containing microcapsules and large void volume. In this study, we developed a novel diversion-type microcapsule-suspension fluidized bed bioreactor (DMFBB). The void volume in the bioreactor and stability of alginate/chitosan microcapsules were investigated under different flow rates. Cell viability, synthesis and metabolism functions, and expression of metabolizing enzymes at transcriptional levels in an encapsulated hepatocyte line (C3A cells) were determined. The void volume was significantly less in the novel bioreactor than in the conventional FBB. In addition, the microcapsules were less damaged in the DMFBB during the fluidization process as reflected by the results for microcapsule retention rates, swelling, and breakage. Encapsulated C3A cells exhibited greater viability and CYP1A2 and CYP3A4 activity in the DMFBB than in the FBB, although the increases in albumin and urea synthesis were less prominent. The transcription levels of several CYP450-related genes and an albumin-related gene were dramatically greater in cells in the DMFBB than in those in the FBB. Taken together, our results suggest that the DMFBB is a promising alternative for the design of a bioartificial liver system based on a fluidized bed bioreactor with encapsulated hepatocytes for treating patients with acute hepatic failure or other severe liver diseases. Public Library of Science 2016-02-03 /pmc/articles/PMC4739599/ /pubmed/26840840 http://dx.doi.org/10.1371/journal.pone.0147376 Text en © 2016 Lu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Lu, Juan Zhang, Xiaoqian Li, Jianzhou Yu, Liang Chen, Ermei Zhu, Danhua Zhang, Yimin Li, LanJuan A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems |
title | A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems |
title_full | A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems |
title_fullStr | A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems |
title_full_unstemmed | A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems |
title_short | A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems |
title_sort | new fluidized bed bioreactor based on diversion-type microcapsule suspension for bioartificial liver systems |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739599/ https://www.ncbi.nlm.nih.gov/pubmed/26840840 http://dx.doi.org/10.1371/journal.pone.0147376 |
work_keys_str_mv | AT lujuan anewfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT zhangxiaoqian anewfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT lijianzhou anewfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT yuliang anewfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT chenermei anewfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT zhudanhua anewfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT zhangyimin anewfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT lilanjuan anewfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT lujuan newfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT zhangxiaoqian newfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT lijianzhou newfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT yuliang newfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT chenermei newfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT zhudanhua newfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT zhangyimin newfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems AT lilanjuan newfluidizedbedbioreactorbasedondiversiontypemicrocapsulesuspensionforbioartificialliversystems |